ArticleScience translational medicine2021

Targeting acute myeloid leukemia dependency on VCP-mediated DNA repair through a selective second-generation small-molecule inhibitor.

Blandine Roux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.